Prostate Cancer Survivor Calls for More Support After Surgery Side-Effects
Mark Roberts, 52, speaks out about erectile dysfunction and incontinence after prostate cancer surgery, calling for better support and a national screening programme.
Mark Roberts, 52, speaks out about erectile dysfunction and incontinence after prostate cancer surgery, calling for better support and a national screening programme.
British doctors warn weight-loss jabs containing semaglutide may cause birth defects; advise contraception and stopping use two months before pregnancy.
MHRA raided an illegal weight-loss drug factory in Northampton, seizing over 2,000 unlicensed pens worth £250,000. Organised crime gangs are making fake branded jabs.
Harvard scientists develop nasal spray antibody CR9114 that protects against all flu strains, showing safety in early trials.
Global health agencies reject Trump's false claims linking paracetamol and vaccines to autism, urging public to ignore his medical advice.
New drug evolocumab cuts bad cholesterol by 60%, reducing heart attack and stroke risk in major trial.
US approves first cancer drug using patient's own cells, Kymriah, priced at $475,000, sparking debate over affordability and effectiveness.
Experts warn fake weight-loss tablets could flood UK market as oral versions of GLP-1 drugs near launch, urging stronger regulation and enforcement.
UK health regulator warns against buying weight-loss jabs from illegal sellers, beauty salons, and social media amid booming black market.
Iran war disrupts petrochemical supply chains, threatening NHS with shortages and rising costs of medicines and medical equipment.
The Ordinary's new growth factor serum delivers impressive anti-ageing results in three weeks, according to a beauty editor's test.
Thousands in UK sue Johnson & Johnson over alleged asbestos in talc, claiming it caused cancer. Company denies allegations.
Michelle McKenna, original member of Platnum, shares her breast cancer journey after starting chemotherapy. She discovered the lump during a miscarriage.
Trump announces plan to cut weight loss drug costs and expand Medicare/Medicaid access for GLP-1s like Ozempic and Wegovy.
Eli Lilly's retatrutide achieves average weight loss of 28.3% in phase three trial, outperforming existing obesity drugs.
Paracetamol is safe for occasional use, but long-term heavy use may pose risks. Learn the facts from Trust Me, I'm a Doctor.
Novo Nordisk cuts 9,000 jobs amid competition from Eli Lilly's Mounjaro and generic drugs, slashing profit forecast.
India's drug safety concerns rise after toxic cough syrups kill children in Jammu and The Gambia, highlighting weak regulation and quality control issues.
ASOS Self Love Club Skincare Beauty Box at £25 saves 57% on viral brands like Anua and Sunday Riley. Includes 3 travel-size and 3 full-size products.
Nearly 90,000 bottles of children's ibuprofen recalled over gel-like mass and black particles; recall upgraded to Class II by FDA.
FDA warns biotech billionaire Patrick Soon-Shiong over misleading claims that his cancer drug can treat or prevent multiple cancers, violating marketing rules.
Two million Britons urged to check antidepressants after a mother's story highlights lack of side effect warnings, including risks of alcohol and suicidal thoughts.
Three studies suggest GLP-1 weight-loss drugs may reduce breast cancer risk and death by up to 30%, with potential benefits in other cancers too.
Julia Donaldson vetoed an ebook of The Gruffalo, fearing interactive apps harm children's reading. She argues digital distractions detract from the text.
UK health chiefs warn against non-sterile alcohol-free wipes after Burkholderia stabilis outbreak kills one and infects 59.
WHO warns shortage of weight loss drugs like Mounjaro will slow fight against obesity, urges lower prices and expanded production.
New daily pill orforglipron shows greater weight loss than oral semaglutide in type 2 diabetes trial, but with higher side effect rates.
New study finds cranberry juice may boost antibiotics against drug-resistant bacteria causing UTIs, but further research is needed.
Eli Lilly pauses UK orders of Mounjaro as demand surges before a 170% price rise in September, causing supply issues and patient concerns.
MHRA warns against counterfeit Ozempic pens after hospitalisations; fake pens may contain insulin.